Cargando…

Identification of metabolism genes related to hepatocarcinogenesis and progression in type 2 diabetes mellitus via co-expression networks analysis

BACKGROUND: Type 2 Diabetes Mellitus (T2DM) is an independent risk factor of hepatocellular carcinoma (HCC). However, the related genes and modules to hepatocarcinogenesis and progression in T2DM remain unclear. METHODS: The microarray data from Gene Expression Omnibus (GEO) were analyzed to screen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Yiming, Yin, Bei, Fan, Guanjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053303/ https://www.ncbi.nlm.nih.gov/pubmed/33865459 http://dx.doi.org/10.1186/s41065-021-00177-x

Ejemplares similares

Studies on Progressive Metabolic Alterations in Thioacetamide Induced Hepatocarcinogenesis
por: Bhide, S. V.
Publicado: (1970)

Molecular Mechanism of the Effect of Huanglian Jiedu Decoction on Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking
por: Yin, Bei, et al.
Publicado: (2020)

CSTF2 Promotes Hepatocarcinogenesis and Hepatocellular Carcinoma Progression via Aerobic Glycolysis
por: Chen, Zhimin, et al.
Publicado: (2022)

Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity
por: Zheng, Xiaoqing, et al.
Publicado: (2017)

Alcohol and hepatocarcinogenesis
por: Taniai, Makiko
Publicado: (2020)

Identification of Pre-Diabetic Biomarkers in the Progression of Diabetes Mellitus
por: Lee, Jae-Ho, et al.
Publicado: (2021)

GLUTATHIONE S‐TRANSFERASES AND HEPATOCARCINOGENESIS
por: Sato, Kiyomi
Publicado: (1988)

Oxidative stress and hepatocarcinogenesis
por: Fu, Ying, et al.
Publicado: (2018)

Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis
por: Wong, Carmen Chak-Lui, et al.
Publicado: (2014)

Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy.
por: Goldfarb, S, et al.
Publicado: (1983)

Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.
por: Pitot, H C, et al.
Publicado: (1991)

Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis
por: Yoo, Jeong Eun, et al.
Publicado: (2017)

Identification of distinct metabolic characteristics of pneumonia in type 2 diabetes mellitus
por: Huang, Jingwen, et al.
Publicado: (2021)

Upregulation of the Wnt Co-Receptor LRP6 Promotes Hepatocarcinogenesis and Enhances Cell Invasion
por: Tung, Edmund Kwok-Kwan, et al.
Publicado: (2012)

Ribonucleic acid as affected by hepatocarcinogenesis.
por: Dessev, G. N., et al.
Publicado: (1969)

Hepatitis C virus and hepatocarcinogenesis
por: Jeong, Soung Won, et al.
Publicado: (2012)

Promotion of Rat Hepatocarcinogenesis by Praziquantel
por: Shirai, Tomoyuki, et al.
Publicado: (1991)

Hepatic Stellate Cells and Hepatocarcinogenesis
por: Barry, Anna E., et al.
Publicado: (2020)

Role of Gut Microbiota in Hepatocarcinogenesis
por: Gupta, Haripriya, et al.
Publicado: (2019)

Genetic Landscape of Multistep Hepatocarcinogenesis
por: Takeda, Haruhiko, et al.
Publicado: (2022)

A Comprehensive Analysis of the Dynamic Biological Networks in HCV Induced Hepatocarcinogenesis
por: He, Bing, et al.
Publicado: (2011)

Identification of independent risk factors for diabetic neuropathy progression in patients with type 2 diabetes mellitus
por: Huang, Linjing, et al.
Publicado: (2021)

Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA)
por: Quagliata, Luca, et al.
Publicado: (2014)

Identification of the Differential Expression Profiles of Serum and Tissue Proteins During Rat Hepatocarcinogenesis
por: Sheng, Xia, et al.
Publicado: (2018)

Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis
por: Lu, Yana, et al.
Publicado: (2020)

Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances
por: Yan, Guoxiu, et al.
Publicado: (2017)

Inflammatory cytokine-induced expression of MASTL is involved in hepatocarcinogenesis by regulating cell cycle progression
por: Cao, Liye, et al.
Publicado: (2019)

NIMA-related kinase 6 as an effective target inhibits the hepatocarcinogenesis and progression of hepatocellular carcinoma
por: Zhang, Hao, et al.
Publicado: (2023)

Specificity of Certain Biochemical Derangements in Hepatocarcinogenesis
por: Reid, E.
Publicado: (1970)

An overview of peroxisome proliferator-induced hepatocarcinogenesis.
por: Rao, M S, et al.
Publicado: (1991)

Hepatocarcinogenesis in liver cirrhosis: imaging diagnosis.
por: Choi, B. I.
Publicado: (1998)

Role of cancer stem cells in hepatocarcinogenesis
por: Wang, Bo, et al.
Publicado: (2011)

Role of Methionine Adenosyltransferase Genes in Hepatocarcinogenesis
por: Ramani, Komal, et al.
Publicado: (2011)

The Suppressive Role of SOX7 in Hepatocarcinogenesis
por: Wang, Chong, et al.
Publicado: (2014)

Molecular Targets in Hepatocarcinogenesis and Implications for Therapy
por: Wu, Meng-Yu, et al.
Publicado: (2018)

PRAS40 hyperexpression promotes hepatocarcinogenesis
por: Qi, Zhaolai, et al.
Publicado: (2020)

The Translational Bridge between Inflammation and Hepatocarcinogenesis
por: Gufler, Sabine, et al.
Publicado: (2022)

Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice
por: Wang, Shanshan, et al.
Publicado: (2021)

Research progress on the relationship between bile acid metabolism and type 2 diabetes mellitus
por: Hou, Yisen, et al.
Publicado: (2023)

Obesity and diabetes accelerate hepatocarcinogenesis via hepatocyte proliferation independent of NF-κB or Akt/mTORC1
por: Arfianti, Evi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jdfkkvd83cmhveje5sdl4aua07